From Nasdaq: 2024-06-07 18:00:13

In the latest trading session, DaVita HealthCare (DVA) closed at $143.18, down 0.46% from the previous day, outperforming the S&P 500. The stock has shown a 4.28% increase in the past month, leading the Medical sector. Analysts expect earnings to rise to $2.47 per share in the upcoming report.

DaVita HealthCare anticipates revenue growth of 5.43% to $3.16 billion in the next quarter. For the year, estimates project earnings per share at $9.62 and revenue at $12.74 billion. Analyst estimate revisions reflect positive sentiment towards the company, with a Zacks Rank of #2 (Buy). The stock currently has a Forward P/E ratio of 14.94.

The Medical – Outpatient and Home Healthcare industry, which includes DaVita HealthCare, ranks in the top 18% of all industries. The Zacks Industry Rank indicates industry strength, with top-rated industries outperforming others by a ratio of 2 to 1. Investors should consider following Zacks for more stock-moving metrics in future trading sessions.

Zacks Investment Research offers access to all its picks for just $1 for 30 days. Options include portfolio services like Surprise Trader and Technology Innovators, known for closing positions with double- and triple-digit gains in 2023. Take advantage of this offer to explore Zacks’ recommendations and insights in the stock market landscape.



Read more at Nasdaq: DaVita HealthCare (DVA) Sees a More Significant Dip Than Broader Market: Some Facts to Know